Immunomic Therapeutics

1 follower

‌

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

William Hearl

CEO, Chairman of the Board & Founder

William Hearl

Collapse

Eric Winzer & Board Member

CFO

Teri Heiland

Chief Scientific Officer

Frances Harrison

SVP, Regulatory Affairs

Scott Rodgers

VP, Clinical Operations

Cara Sholter

VP, Quality Assurance

Eric Winzer

CFO

Teams

View all

Board of Directors

12 members

Leadership Team

3 members

CEO and Executive Team

3 members

Discover similar companies

Kineta

1 follower

Leap Therapeutics

1 follower

First Wave BioPharma

1 follower

MedRhythms

1 follower

Halo Labs

1 follower